Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11196267

Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Pediatr Hematol Oncol
Publication date
2001 Jan
First author
Cairo MS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Pediatr Hematol Oncol. 2001 Jan;23(1):2-6. doi: 10.1097/00043426-200101000-00002.
    note
    Source null
    related pmid
    11196265
    relationship
    Comment in

Authors and identifiers

  1. name
    Cairo MS
    type
    Author
  2. name
    Shen V
    type
    Author
  3. name
    Krailo MD
    type
    Author
  4. name
    Bauer M
    type
    Author
  5. name
    Miser JS
    type
    Author
  6. name
    Sato JK
    type
    Author
  7. name
    Blatt J
    type
    Author
  8. name
    Blazar BR
    type
    Author
  9. name
    Frierdich S
    type
    Author
  10. name
    Liu-Mares W
    type
    Author
  11. name
    Reaman GH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cairo MS
    type
    Author
  2. name
    Shen V
    type
    Author
  3. name
    Krailo MD
    type
    Author
  4. name
    Bauer M
    type
    Author
  5. name
    Miser JS
    type
    Author
  6. name
    Sato JK
    type
    Author
  7. name
    Blatt J
    type
    Author
  8. name
    Blazar BR
    type
    Author
  9. name
    Frierdich S
    type
    Author
  10. name
    Liu-Mares W
    type
    Author
  11. name
    Reaman GH
    type
    Author
bibliography ids
  1. nci-bib-c27bf8cd708e14ad8422813f
book metadata
content sha256
6b213ab34dc765fef37a97867b3adbd08b0a13a11ad37912421d3cbea57a6fb7
document type
citation
dois
  1. 10.1097/00043426-200101000-00008
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:11196267
immutable id
pubmed:11196267@6b213ab34dc765fef37a97867b3adbd08b0a13a11ad37912421d3cbea57a6fb7
journal
abbreviation
J Pediatr Hematol Oncol
issn electronic
Source null
issn print
1077-4114
issue
1
name
Journal of pediatric hematology/oncology
nlm unique id
9505928
pages
30-8
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Pediatr Hematol Oncol. 2001 Jan;23(1):2-6. doi: 10.1097/00043426-200101000-00002.
    note
    Source null
    related pmid
    11196265
    relationship
    Comment in
outcomes validated
false
pmid
11196267
provenance
batch id
30d2cd7affbbb92b6784
provider
NCBI PubMed ESummary
record sha256
4ce6878582d89ee41c9834c7c78fcdcb87d480f0e0c6b4a31885769fa8b1f828
response sha256
ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
retrieved at
2026-09-09T23:45:39.779418+00:00
publication date
display
2001 Jan
precision
month
year
2001
publication types
  1. Clinical Trial
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/11196267/
title
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Preserved source evidence · Not medical advice